169267 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of the uterus and endometrial
MOLECULAR PROFILING OF TUMORS
#2BIOMARKERS FOR ENDOMETRIAL CANCER
#3MOLECULAR PROFILING OF TUMORS
#4SELF-ADMINISTERED SYSTEM FOR BREAST CANCER SCREENING AND DIAGNOSIS USING BIOMARKER-SPECIFIC ANALYSIS
#5EXTRACELLULAR VESICLE BIOMARKERS FOR ENDOMETRIAL CANCER
#6PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER
#7Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
#8USE OF HE4 AND OTHER BIOCHEMICAL MARKERS FOR ASSESSMENT OF OVARIAN CANCERS
#9SYSTEMS AND METHODS FOR DETECTING A DISEASE CONDITION
#10SYSTEMS AND METHODS FOR DETECTING A DISEASE CONDITION
#11USE OF HE4 AND OTHER BIOCHEMICAL MARKERS FOR ASSESSMENT OF OVARIAN CANCERS
#12CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
#13PAPANICOLAOU TEST FOR OVARIAN AND ENDOMETRIAL CANCERS
#14MARKERS OF ENDOMETRIAL CANCER
#15METHODS AND MATERIALS FOR TREATING ENDOMETRIAL CANCER
#16MOLECULAR PROFILING OF TUMORS
#17USE OF DKK-1 INHIBITORS FOR TREATING CANCER
#18METHOD FOR PERITONEAL METASTATIC CELL DETECTION AND ISOLATION THEREOF
#19LIPID BIOMARKERS FOR CANCER SCREENING AND MONITORING
#20EXTRACELLULAR VESICLE BIOMARKERS FOR ENDOMETRIAL CANCER
#21USE OF MCM5 AS A MARKER FOR GYNAECOLOGICAL CANCERS
#22A BIOMARKER FOR PREDICTING THE PROGNOSIS FOR AN ENDOMETRIAL CANCER PATIENT
#23BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND A PD-1 ANTAGONIST
#24METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS AND ENDOMETRIOSIS-RELATED DISORDERS
#25METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#26Self-recovery of Preimplantation Stage Human Embryos and Characterization of their Morphological, Physiological and Genomic Features
#27Biosensors and methods for detection of lysophosphatidic acid for signaling of ovarian cancer
#28Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
#29DIAGNOSTICS OF GYNEACOLOGICAL DISEASES, ESPECIALLY EPITHELIAL OVARIAN CANCER
#30CTNB1 AS A MARKER FOR ENDOMETRIAL CANCER
#31Data acquisition method for determining likelihood that ovarian endometriotic cyst is cancerous, and diagnostic device for same
#32PME-1 AS A BIOMARKER TO PREDICT AND DIAGNOSE AN INCREASED RISK OF ENDOMETRIAL CANCER AND GENE SILENCING OF PME-1 TO INHIBIT EPITHELIAL TO MESENCHYMAL TRANSITION
#33USE OF HE4 AND OTHER BIOCHEMICAL MARKERS FOR ASSESSMENT OF OVARIAN CANCERS
#34MOLECULAR PROFILING OF TUMORS
#35Systems and methods for determining a treatment course of action
#36Method for diagnosing genitourinary cancers
#37Markers of Endometrial Cancer
#38METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#39METHOD AND APPARATUS FOR ENDOMETRIAL SCREENING
#40METHOD OF DIAGNOSING, TREATING AND DETERMINING PROGRESSION AND SURVIVAL OF CANCER CELLS USING BCL-2 ANTAGONIST OF CELL DEATH (BAD) PATHWAY GENE SIGNATURE
#41Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
#42USE OF CYP EXPRESSION TO DIRECT THERAPEUTIC INTERVENTION IN CANCER
#43Diagnostics of gyneacological diseases, especially epithelial ovarian cancer
#44USE OF HE4 AND OTHER BIOCHEMICAL MARKERS FOR ASSESSMENT OF OVARIAN CANCERS
#45METHOD FOR THE DIAGNOSIS OF ENDOMETRIAL CARCINOMA
#46NEW MARKERS FOR EARLY DIAGNOSIS OF OVARIAN CANCER, MONITORING DURING THERAPY, AND NEW THERAPY OPTIONS DURING AND AFTER CHEMOTHERAPY
#47Method and treatment of recurring endometrial cancer with an inhibitor of USP14
#48PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#49Anti-folate receptor alpha antibodies and uses thereof
#50Data acquisition method for determining likelihood that ovarian endometriotic cyst is cancerous, and diagnostic device for same
#51Antibodies, antibody drug conjugates and methods of use
#52METHODS FOR DETECTING, DIAGNOSING AND TREATING ENDOMETRIAL CANCER
#53METHOD OF EVALUATING FEMALE GENITAL CANCER
#54MOLECULAR PROFILING OF TUMORS
#55Methods of diagnosing, classifying and treating endometrial cancer and precancer
#56Systems and methods for characterizing kidney diseases
#57Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
#58ASRGL1 IN ENDOMETRIAL CANCER
#59Gene signature to predict homologous recombination (HR) deficient cancer
#60Antibodies which bind to epithelial membrane protein 2 (EMP2)
#61Papanicolaou test for ovarian and endometrial cancers
#62Systems and methods for determining a treatment course of action
#63Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature
#64Anti-mesothelin antibodies and immunoconjugates
#65Retrieval of biological materials from the human uterus, ovary and cervix by suction
#66Endometrial phase or endometrial cancer biomarkers
#67METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#68Anti-folate receptor alpha antibodies and uses thereof
#69PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#70Prognostic marker for endometrial carcinoma
#71Anti-folate receptor alpha antibodies and uses thereof
#72Compositions and methods for detecting, diagnosing, and treating cancer
#73METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#74PLA2ACTIVITY AS A MARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS
#75Anti-folate receptor alpha antibodies and uses thereof
#76METHOD FOR THE EARLY DETECTION OF HIGH-GRADE PELVIC SEROUS CANCER
#77Methods for diagnosis and treatment of endometrial cancer
#78Anti-mesothelin antibodies and immunoconjugates
#79Systems and methods for characterizing kidney diseases
#80Flap Endonuclease-1 As A Marker For Cancer
#81Diagnosis and treatment of cancer using anti-TMPRSS11E antibody
#82Markers for endometrial cancer
#83METHOD FOR DIAGNOSING ENDOMETRIAL CANCER
#84Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
#85METHOD FOR DETECTING GYNECOLOGIC CANCER
#86Prognostic Marker for Endometrial Carcinoma
#87Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#88METHOD OF EVALUATING FEMALE GENITAL CANCER
#89MARKER FOR ESTIMATING THE DIAGNOSIS OF CERVICAL ADENOCARCINOMA OR FOR ESTIMATING THE PROGNOSIS OF CERVICAL CANCER
#90REAGENT FOR DETECTING ABNORMAL CELL IN CERVIX OF UTERUS, AND METHOD FOR DETECTING ABNORMAL CELL IN CERVIX OF UTERUS BY USING SAME
#91METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#92PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY
#93BIOMARKERS FOR ENDOMETRIAL DISEASE
#94Biomarkers for detection of early- and late-stage endometrial cancer
#95Methods for diagnosing and treating cancers
#96Detection of uterine leiomyosarcoma using LMP2
#97Molecular profiling of tumors
#98METHOD FOR DIAGNOSING SELECTED ADENOCARCINOMAS
#99Method of diagnosing, monitoring, staging, imaging and treating various cancers
#100Methods for Diagnosis and Treatment of Endometrial Cancer
#101Endometrial biomarkers
#102Cancer marker and therapeutic agent for cancer
#103METHOD OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#104Biomaker for ovarian and endometrial cancer: hepcidin
#105Methods of treating smooth muscle cell disorders
#106SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#107Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
#108Diagnostic methods
#109Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase
#110Neoplasia-Specific tNOX Isoforms and Methods
#111Method for detecting risk of progression of low grade cervical dysplasia
#112Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#113Methods of detecting ovarian cancer
#114NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER
#115PIK4CA as modifier of the Rac pathway and methods of use
#116Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
#117Methods For Detecting Markers Associated With Endometrial Disease or Phase
#118Biomarker for gestational trophoblastic disease
#119Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
#120Method and composition for diagnosing endometrial cancer
#121Polypeptide useful for cancer diagnosis and treatment
#122Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1)
#123Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
#124Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
#125Cell collection and disease screening
#126Use of HE4 and other biochemical markers for assessment of ovarian cancers
#127Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)
#128METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#129METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS
#130Systems and methods for characterizing kidney diseases
#131Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas
#132Method for diagnosing selected adenocarcinomas
#133Use of adiponectin to diagnose and treat malignancy
#134Biomarker for ovarian and endometrial cancer: hepcidin
#135Method for prognostic evaluation of carcinoma using anti-P-LAP antibody
#136DIAGNOSING AND TREATING CANCER
#137Interleukin-8 homologous polypeptides and therapeutic uses thereof
#138Cancer-linked gene as target for chemotherapy
#139Interleukin-8 homologous polypeptides and therapeutic uses thereof
#140Erk7 and erk8, novel diagnostic markers for cancer
#141Method for diagnosing and treating NIS-expressing carcinomas and metastases
#142Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent
#143Methods of treating smooth muscle cell disorders
#144Diagnosing and treating cancer
#145Systems and methods for characterizing kidney diseases
#146Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself
#147Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#148Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
#149Novel method for the detection of cancer biomarkers in cervical specimens
#150Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
#151Compositions and methods relating to endometrial specific genes and proteins
#152Detection of endometrial pathology
#153Complexes and methods of using same
#154Interleukin-8 homologous polypeptides and therapeutic uses thereof
#155Use of adiponectin to diagnose and treat malignancy